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Abstract
Innate immunity is evolutionarily conserved in multicellular organisms and was considered
to lack memory until very recently. One of its more characteristic mechanisms is phagocyto-
sis, the ability of cells to engulf, process and eventually destroy any injuring agent. We
report the results of an ex vivo experiment in bovine macrophages in which improved clear-
ance of Mycobacterium bovis (M. bovis) was induced by pre-exposure to a heat killed M.
bovis preparation. The effects were independent of humoral and cellular adaptive immune
responses and lasted up to six months. Specifically, our results demonstrate the existence
of a training effect in the lytic phase of phagocytosis that can be activated by killed myco-
bacteria, thus suggesting a new mechanism of vaccine protection. These findings are com-
patible with the recently proposed concept of trained immunity, which was developed to
explain the observation that innate immune responses provide unspecific protection
against pathogens including other than those that originally triggered the immune
response.
Introduction
Innate immunity is evolutionarily conserved in multicellular organisms and is the most primitive
component of the immune system. It is based on non-specificmechanisms that, in contrast to
the adaptive immune response, were considered to lack memory until very recently. The tradi-
tional paradigm in immunology is that innate immunity—as opposed to adaptive immunity—
lacks of memory-like properties. In plants and invertebrates, however, memory effect for innate
host defence has been recently recognizedand defined as training to differentiate from specific
immunememory. Therefore, the term 'trained immunity' was proposed to describe the
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potentiating effects of an exposure to microbial agents or vaccines on innate immune responses,
which would thus mount a more effective immune response against related and sometimes even
unrelated infections. This training leads to increased cytokine production via epigenetic repro-
gramming of monocytes [1]. Although the epidemiological evidence of Bacille Calmette-Guérin
(BCG) vaccine effectiveness against tuberculosis is referred to as proof of the trained immunity
concept in higher animals [2], no experimental evidence has been produced to support the
hypothesis that phagocytosismight be playing a critical role in this process.
Here, we report an improved clearance ofMycobacterium bovis in bovinemacrophages lasting
up to six months and independent of specific immune responses. To discriminate between the
adaptive and innate immune responses in cattle sensitizedwith a killedM. bovis preparation,
monocyte derivedmacrophages (MDM) from sensitized and control cattle were tested ex vivo
for phagocytic activity whilemonitoring for systemic specific immune responses. Our results
demonstrate the existence of a training effect in the lytic phase of phagocytosis that can be acti-
vated by killedmycobacterial cells. This suggests a newmechanism of immune protection by
which low-intensity priming enhances early phagocytic responses independently of humoral and
cellular adaptive immune responses for, at least, six months. This mechanismwould support the
empirical evidence of protection induced by killedmycobacterial vaccines [3,4,5]. These findings
fit well with the recently proposed general concept of trained immunity, which was developed to
explain the observation that innate immune responses provide unspecific protection against
pathogens including other than those that originally triggered the immune response.
Materials and Methods
Ethics statement
Animals used in this study were submitted only to procedures that according to European
(Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010
on the protection of animals used for scientific purposes. Chapter 1, Article 1, Section 5, para-
graphs b and f) and Spanish (Real Decreto 53/2013, de 1 de febrero, por el que se establecen las
normas básicas aplicables para la protección de los animales utilizados en experimentación y
otros fines científicos, incluyendo la docencia, Article 2, Section 5, Paragraphs b and f) legisla-
tion on experimental animals are exempt from its application. The animals, belonging to a reg-
istered commercial farm supervisedby the local livestock authority (Serviciode Ganadería de
la Diputación Foral de Bizkaia) were submitted only to the introduction of a needle in accor-
dance with good veterinary practice and were not killed in relationship with this study.
Animals and treatment
Twenty-five 3- to 6-month-old Limousin (6), Pyrenean (8) or crossed (11) cattle originally pur-
chased from 8 different farms and currently housed in a small commercial feedlot were intramus-
cularly injectedwith 2 ml of a suspension of heat-inactivated cells of a localM. bovis isolate
(NEIKERMS#1403) inMontanide 50 (SEPPIC, Paris, France) (MdR) or left untreated. Ten ani-
mals received a full dose of 107 colony forming units (CFU) (FD group), ten a reduced dose of 103
CFU (RD group), and 5 animals servedas untreated controls (UC group). All breeds were present
in each treatment group. Two animals from the FD group, 3 from the RD group and 2 from the
UC group were lost because of unrelated disease (1), traumatism (1) or sale (5) before the final test.
Humoral immune response: ELISA test
On day 0, immediately before treatment, and at 15, 43, 78 and 186 days post-treatment (dpt),
bloodwas obtained from each animal via the tail vessels and collected in EDTA Vacutainer
Trained Macrophages
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tubes (Becton,Dickinson and Company, Sparks, MD, USA). The blood samples were analysed
using an in-house anti-M. bovis ELISA with bovine PPD as the antigen [5]. This assay includes
a serumMycobacterium phlei pre-absorption step to reduce non-specific reactivity caused by
environmental mycobacteria. The results of this test were expressed as relative optical density
(OD) calculated as raw serumOD divided by the OD value of the positive control.
IFN-γ release assay (IGRA)
Immediately before treatment and at 15, 43, 78 and 186 dpt blood stimulation was performed
within the first 8 h after sampling in 24-well culture plates (Becton-Dickinson1, Franklin
Lakes, NJ) with either phosphate-buffered saline (PBS), avian purified protein derivative
(PPDAV) (CZ Veterinaria1 SA, Porriño, Spain) or bovine purified protein derivative
(PPDBOV) (CZ Veterinaria1 SA, Porriño, Spain) tuberculin. After incubation for 16–24 h at
37°C + 5–7% CO2, plasma was separated by centrifugation and frozen at -20°C until testing.
Subsequently, a commercial IGRA (BovigamTM, Fisher Scientific, Schlieren, Switzerland) was
performed in accordance with the manufacturer’s instructions.
Intradermal reaction
At 46 and 81 dpt, each animal was intradermally inoculated at three spots on each side of the
neck (ST) with 0.1 ml of standard bovine and avian tuberculin (CZV, SA. Porriño, Spain) or
PBS using a Dermojet device (AKRADermojet, Pau, France). Reactions were read after 72 h
according to the Spanish TB control program regulations.
Phagocytosis assay
The phagocytosis assays were performed at 78 and 186 dpt to estimate the bacterial load reduc-
tion associated with each treatment as previously described [6,7]. For the first phagocytic assay,
peripheral bloodwas drawn into heparinizedVacutainer tubes, diluted 1:2 in Hanks balanced
salt solution (HBSS), layered over 10 ml of Ficoll-Paque gradient (1.084 g/cm3) and centrifuged
at 900 x g for 30 min. The cell interphase was collected and centrifuged at 400 x g for 10 min to
remove platelets from peripheral bloodmonocytic cells (PBMCs). For the second test, macro-
phages were magnetically enriched from PBMCs using magnetic activated cell sorting (MACS)
technology (Miltenyi Biotech, BergischGaldbach, Germany). In both cases, bovine monocytes
were resuspended in RPMI-1640 supplemented with 20 mM L-glutamine, 10% heat-inacti-
vated bovine serum, 100 Uml-1 penicillinG and 100 mg ml-1 streptomycin sulfate (Lonza) and
seeded into 24-well plates at a density of 4 x 105 cells ml-1. After 2 h at 37°C in a humidified 5%
CO2 incubator, non-adherent cells were removed. Adherent cells were incubated for 7 days at
37°C to allow differentiation to MDM prior to infection.DifferentiatedMDMs were inoculated
with a single-cell suspension ofM. bovis at an MOI (multiplicity of infection; bacteria:cells) of
10:1. After 2 h and 7 days, the supernatant was removed from three wells, and the cells were
washed twice with HBSS to remove extracellular bacteria. Infectedmacrophages were lysed by
vigorous pipetting with 0.5 ml of 0.1% Triton X-100 (Sigma-Aldrich) in sterile water for 10
min. Supplemented Mycobacteria Growth indicator tubes (MGIT) (Becton,Dickinson and
Company, Sparks, MD) were inoculatedwith 0.1 ml of each initial bacterial suspension and
with the 2 h and 7 d p. i. cell lysates. The tubes were incubated at 37 ± 2°C for up to 41 days in
a BactecMGIT 960 instrument (Becton,Dickinson and Company). The earliest instrumental
indication of positivity (i.e., time to detection [TTD]) for each tube was recorded. The pre-
dicted number of bacteria in each positive tube was calculated using previously generated
mathematical formulas which relate TTD (in days) to estimated log10 CFUs. Bacterial cell
Trained Macrophages
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reduction between 2 h and 7 days p.i. were calculated by dividing the estimated log10 CFUs at
day 7 by that at 2 h p.i.
Cytokines gene expression
At 186 dpt, MDMs purified from peripheral blood of treated and untreated animals were
infected ex vivowithM. bovis. At 24 h pi, the infectedMDMwere washed in 0.5 ml of cold
HBSB, mixed with 50 μl of Lysis Solution and incubated at room temperature for five minutes
to allow RNA release into the Lysis solution (PowerSYBR1 Green Cells-to-Ct kit (Life Tech-
nologies, Carlsbad, CA). DNAse I was added to the Lysis Solution to allow genomic DNA deg-
radation at this step. Next, 5 μl of Stop Solution were mixed into the lysate to inactivate the
lysis solution so that it would not interfere with the reverse transcription (RT) or polymerase
chain reaction (PCR). Cell lysates (10 μl) were then reverse transcribed to synthesize cDNA
using 2.5 μl of 20 X RT EnzymeMix, 25 μl of 2X SYBR RT Buffer, and 12.5 μl of Nuclease-free
water. The reactionmixtures were incubated at 37°C for 60 min and then at 95°C for 5 min to
inactivate the RT enzyme. Finally, the synthesized cDNAs were amplified by real-time PCR
using Power SYBR Green PCRMaster Mix and PCR primers for the bovine IL1-α, TGF-β,
BCL2, TNF-α and C3 genes as previously described [6]. The β-actin gene was used as the
endogenous control gene in the assays. To determine the changes in gene expression (Relative
quantification, RQ), the following formula was used: RQ = 2-Δ(ΔCT) were ΔCT is CT (target
gene)—CT (β-actin) and Δ(ΔCT) is ΔCT (experimental)—ΔCT (control). Results were expressed
as RQ of transcription compared to those of control uninfected cells.
Statistical analysis
ELISA and IGRA optical density readings, estimated bacterial counts, reductions in bacterial
load and cytokine expression estimates were compared using the GLM procedure in the SAS
9.1 software (SAS Institute, Cary, NC) with the Tukey-Kramer multiple-comparison post-test.
Correlations between variables to explore their association with innate or adaptive responses
were examined by the Kendall correlation and principal component analysis with SAS soft-
ware. In all predictive analyses, differences were considered statisticallly significant at p<0.05.
Results
Assessment of humoral and cell-mediated immune responses in cattle
treated with a heat killed M bovis preparation
For adaptive immunity, three standard tests based on humoral and cell-mediated immune
responses were conducted to determine: i) antigen-specific antibody production, ii) IFN-γ
release by peripheral blood lymphocytes and iii) cell infiltration into the skin [8]. None of the
treated groups exhibited humoral responses at 0, 15 and 43 dpt) (Fig 1A). However, the group
treated with the highest dose of the killedM. bovis preparation displayed a significant increase
in antibody levels by day 78 that were slightly higher by day 186. The control and low-dose
groups on day 186 also exhibited slight increases in antibody levels relative to their minimal
readings, but the antibody levels did not differ among these groups. These patterns are consis-
tent with the anamnestic effect of the tuberculin antigens used in the skin test, which increases
the reactivity of infected anergic animals [9]. The cellular response as measured by IFN-γ
release assay (IGRA) by peripheral blood lymphocytes revealed a substantial specific response
by 15 dpt in the FD group that was significantly different from that of the control group (Fig
1B). However, both the control and low-dose immune responses converged at a very low level
on day 43 when the immune response of the FD group reached a maximum.
Trained Macrophages
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Regarding the intradermal test, at the first test only the FD group exhibited a significant
increase in mean skin thickness, whereas the control and low-dose RD groups exhibited negli-
gible increases in skin thickness. By the second test, the high-dose group remained at a similar
reactivity level, whereas reactivity remained very low in both the control and RD groups. With
the exception of the low-level response of the RD group, these specific immune response
dynamics were consistent with expectations.
M. bovis phagocytosis assessment in bovine macrophages purified from
blood of treated and untreated cattle
At 78 and 186 dpt, MDM purified from peripheral blood of treated and untreated animals
were infected ex vivowithM. bovis. Bacterial load associated with each treatment at 2 h and 7
days p. i. was estimated as previously described [6,7]. In the phagocytosis test, bacterial cell
uptake did not differ among the groups (S2 Table). Fig 2 summarises the results of the two
phagocytosis assays for average bacterial load reduction at 7 days p. i. The FD group exhibited
an average reduction of 83.37%, whereas the RD group displayed a reduction of 88.03%. By
contrast, the bacterial load increased slightly in the control group. Notably, in the phagocytosis
assay performed at 78 dpt, the control group exhibited an approximately 50% reduction that
made the reductions in the treated groups appear less dramatic by comparison over time
(Table 1). This response could be a short-term effect caused by intradermal sensitization with
tuberculin or it might be related to individual variation. Interestingly, the rate of infection
clearance was much higher in this sampling than in the sampling conducted three months
after the last skin test (186 dpt). This smaller but more widespread reduction together with the
variable reductions shortly after skin sensitization or boosting and three months later suggest
that phagocyticmemorymight not be constant and definitive but vary with time and tend to
wane after several months. This effect of the treatment on the macrophages lytic capability has
not been describedpreviously and may have important implications for explaining natural and
vaccine protection mechanisms during chronic intracellular infections.
Assessment of cytokine profiles in MDMs purified from treated and
untreated cattle and infected ex vivo with M. bovis
At 24 h pi, RNA was extracted fromM. bovis-infectedMDMs and reverse transcribed to cDNA
to measure IL1-α, TGF-β, BCL2, TNF-α and C3 expression levels by using qRT-PCR (S2
Table). The cytokine profiles of the groups did not differ significantly, except the C3 levels,
which were significantly higher in both treated groups when compared to controls (p = 0.0006;
p = 0.0327). Furthermore, C3 expression levels were significantly higher in the FD group than
Fig 1. Immune dynamics throughout the experiment. (A) ELISA: Specific humoral immune response in
relative optical density units in TB ELISA. * Comparison between MdR-FD and Control (p = 0.0007) and
MdR-RD (<0.0001) groups at day 78. ** Comparison between MdR-FD and Control (p = 0.0239) and
MdR-RD (p<0.0110) groups at day 186. Other days differences are not statistically significant at p<0.0500.
(B) IFN: Specific cellular immune response in optical density units in Interferon γ release assay. *
Comparison between MdR-FD and Control (p = 0.0061) and MdR-RD (p = 0.0051) groups at day 15. **
Comparison between MdR-FD and Control (p = 0.0003) and MdR-RD (<0.0110) groups at day 43. ***
Comparison between MdR-FD and Control (p = 0.0190) and MdR-RD (p = 0.0580) groups at day 78. ****
Comparison between MdR-FD and Control (p = 0.0043) and MdR-RD (p<0.0001) groups at day 186. Other
days differences are not statistically significant at p<0.0500. (C) Skin test: Mean group skin test results in
mm. * Comparison between Control and MdR-FD (p<0.0001) or MdR-RD (p = 0.9678) and between both
MdR groups (p<0.0001) at day 43. **Comparison between Control and MdR-FD (p<0.0001) or MdR-RD
(p = 0.5456) and between both both MdR groups (p<0.0001) at day 78. Control: Untreated control group.
MdR-FD: Full-dose group. MdR-RD: Reduced-dose group.
doi:10.1371/journal.pone.0165607.g001
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the RD group (p = 0.0042). This finding is consistent with the previously reported increase in
the expression of C3 in wild boar tissues treated with this inactivatedM. bovis-based immuno-
gen [5, 10]. In addition, the up-regulation of C3 in the lymph nodes and tonsils has been corre-
lated with tuberculosis resistance in wild boar [11].
Relationships between immunological variables
Principal component analysis revealed two main associations between the studied variables
(Fig 3). The first component represented the specific immune response because humoral and
cellular specific response variables tended to cluster on the positive end. The second compo-
nent represented bacterial lysis because the bacterial load at 7 days and load reduction clearly
aligned along this axis. Strikingly, these two variables did not exhibit any correlation with the
first component, suggesting that phagocytic activity decreases as specificmechanisms become
dominant in the immune response. Therefore, phagocytosis becomes less relevant as more spe-
cific mechanisms are triggered. The lack of correlation between specificmechanisms and actual
M. bovis clearance suggest that the innate component of the immune response is uncoupled
from both specific responses and bacterial uptake.
Discussion
Our results demonstrate that sensitizing young animals with an inactivatedmycobacterial
preparation by the parenteral route can boost the bacterial killing efficiencyof infectedmacro-
phages. This is the first study to demonstrate a memory effect on phagocytic lysis in a higher
mammal. This phenomenon differs from that reported in invertebrates, in which the learning
effect appears to occur only at the uptake phase [12]. Because no cells other than macrophages
were supposed to be present in our MDM infected cultures given that both variants of selective
Fig 2. Average mycobacterial load reduction according to the treatment calculated as the quotient
between log10 CFU at 2 h minus log10 CFU at 7 days and log10 CFU at 2 h. The four decimal numbers in the
base of the bars are the p values for differences between the control and sensitized groups. The number between
MdR-FD and MdR-RD at the end of the bars represent the p value for the difference between sensitized groups.
Control: Untreated control group. MdR-FD: Full-dose group. MdR-RD: Reduced-dose group.
doi:10.1371/journal.pone.0165607.g002
Trained Macrophages
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procedures applied yielded similar results, it could be assumed that the memory effect was
maintained by macrophages themselves and not by lymphocytes interacting with them. Addi-
tionally, both the lack of correlation with specific cellular and humoral immune responses and
the positive association with the non-specific IFN-γ response further demonstrate that phago-
cytosis does not depend on specific immune responses. Our results confirm that trained immu-
nity is present in organisms other than mice and lower vertebrates at the macrophage level.
Most importantly, our results indicate that this effect remains active in young adults for at least
six months after exposure. Intriguingly, lower doses of killed-mycobacteriamight be more effi-
cient at inducing trained immune responses than higher doses, in agreement with field obser-
vations [3, 13, 14].
Mycobacteria are powerful immunogens, and this property has long been used to stimulate
immune responses by adding mycobacteria immunogens to antigens of interest in complete
Table 1. Results of the phagocytosis assays.
MD78 MD186
Treatment Calf code Uptake 7 days Reduction Uptake 7 days Reduction
Time Treatment Time Treatment
Full Dose 1656 C 6.0183 0.0000 100% • 83%a
• 63%b
• 83%c
. . . • 84%a
• 78%b
• 14%c
1657 C . . . . . .
3621 L . . . 3.2502 0.7869 76%
4159 C . . . 3.9288 0.5586 86%
4166 C 5.9311 0.0000 100% 4.5379 0.0000 100%
4168 C 6.4247 6.3932 0% 3.9444 0.7647 81%
4170 C . . . . . .
6314 P 6.4535 0.0000 100% 5.2150 0.6587 87%
6315 P 6.2336 0.0000 100% 3.6865 0.9331 75%
6568 C 6.8783 0.0000 100% 3.7228 0.7680 79%
Reduced Dose 0723 L 5.6854 0.0000 100% • 95%a
• 88%b
• 67%c
4.3161 0.6490 85% • 89%a
• 89%b
• 16%c
1654 L . . . . . .
1655 P . . . . . .
4160 L . . . 4.5011 0.8700 81%
4163 C 6.5538 1.3163 80% 6.1269 0.6506 89%
4164 L 6.7075 0.0000 100% 5.5988 0.0000 100%
4167 C . . . 5.1879 0.5797 89%
5049 P 6.6816 0.0000 100% 4.5457 0.7110 84%
6310 P 6.4247 0.7983 88% . . .
9681 P 6.7596 0.0000 100% . . .
Control 1658 C 6.4247 0.0000 100% • 56%a
• 0%b
• 50%c
. . . • -15%a
• 0%b
• 0%c
3877 C . . . . . .
4165 L 6.3833 5.4100 15% 4.7049 6.0817 -29%
6312 P 6.3428 6.0872 4% 5.3117 5.9606 -12%
9682 P 6.8916 0.0000 100% 3.6748 3.6748 0%
Individual bacterial cell reduction (Time) between 2 h and 7 days p.i. were calculated by dividing the difference between the estimated log10 CFUs at day 7
and that at 2 h p.i. by the log10 CFU at 2 h p.i. Group bacterial reduction was calculated as follows
a Mean log10 CFU reduction from uptake to end of culture at 7 days p.i.
b Reduction in mean log10 CFU in the treated group compared with the control group
c Proportion of individuals with 100% reduction in the bacterial load in macrophages.
C: Crossed; P: Pyrenean; L: Limousin.
doi:10.1371/journal.pone.0165607.t001
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Freund’s adjuvant [15]. This immunogenicity is consistent with the high stability of immune
response-inducing genes, which is interpreted as an evolutionary adaptation favouring long-
term survival in organs and subsequent dissemination [16, 17]. In addition, mycobacterial vac-
cines prevent other diseases non-specifically [2, 18, 19]. This study results suggest that the long
held principle that tuberculosis killed vaccines do not work might not be true and that Tuber-
culosis vaccination could be achieved without using live bacilli, which pose a risk to immuno-
compromised individuals of any age who submit to BCG therapy, such as cancer patients. It is
very important to define appropriate immunization protocols that can take advantage of the
non-specific and powerful effect of killed vaccines on phagocytosis. These vaccination strate-
gies may also provide protection against infections or immune dysfunctions other thanM.
bovis. Another interesting finding of this study, which unfortunately could not be extended, is
that the training effect of macrophage phagocytosis persists for at least several months.
In summary, we present evidence that bovine macrophages can be “trained” to improve
their lytic capacity, rather than just particle uptake, likely by epigenetic reprogramming [20,
21]. Our results are consistent with the concept of trained innate immunity recently proposed
by Netea et al. [1]. Evidence from this study suggests that efficient priming of the phagocytic
Fig 3. Principal component analysis of the relationships between variables. Note that bacterial uptake is negatively
correlated with humoral and cellular specific immune responses. The bacterial reduction exhibits no correlation with these
specific variables. Bacterial reduction defines the second factor, which is weakly correlated with the non-specific IFN
response. IFNBOV: IFN with bovine PPD; IFNAVI: IFN with avian PPD; IFNPBS: IFN blank; IDBOV: intradermal test with
bovine PPD; IDAVI: intradermal test with avian PPD; IDPBS: intradermal test blank; CFU2H: M. bovis CFU logarithm at 2
h after culture inoculation; CFU 7D: M. bovis CFU logarithm at 7 days after culture inoculation; MYCRED: M. bovis CFU
reduction between 2 h and 7 days after inoculation.
doi:10.1371/journal.pone.0165607.g003
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innate mechanisms can be induced by contact with bacterial structures present in killed slow-
growingmicrobes. The challenge of faster-growing pathogens that can easily overwhelm the
innate immune system would have prompted the development of an adaptive immune system
that is not only able to address intracellular slower-growing microbes, but also requires larger
amounts of stimuli to be triggered.Mastering the training of the innate mechanisms could
cause a revolutionary shift in the preventive and therapeutic use of immunogens covering an
extraordinarily broad range of diseases, from viral to chronic inflammatory and neoplastic dis-
eases [22].
Supporting Information
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